📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects. (2019)

First Author: Mofenson LM

Attributed to: Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/jia2.25352

PubMed Identifier: 31298496

Publication URI: http://europepmc.org/abstract/MED/31298496

Type: Journal Article/Review

Volume: 22

Parent Publication: Journal of the International AIDS Society

Issue: 7

ISSN: 1758-2652